Diabetes

Blog, News, Companies, blood glucose meters, oral, Nasal, transdermal, insulin,type 2, pancreatic islet cells, Macular Edema, Ulcers, continuous glucose monitoring, HbA1c, hemoglobin A1C, oral anti-diabetic agent, data management system, Hypoglycemia, glucagon, therapeutic vaccine, peripheral neuropathy, Neuropathic pain, diabetes mellitus, type 1, foot ulcers, test strip, glycemic control, nephropathy, resistant, sensitizers, foot infections, sensor, retinopathy, non-invasive monitor...

Thursday, September 27, 2007

Innocoll , phase 2 clinical trials for the treatment and prevention of infected diabetic foot ulcers

September 26, 2007 – Innocoll, Inc., a privately-held specialty pharmaceutical company, announced the following status and progress updates regarding its clinical development programs and specialty pharmaceutical operations:
.....CollaRx® GENTAMICIN TOPICAL to commence a series of phase 2 clinical trials for the treatment and prevention of infected diabetic foot ulcers... Innocoll 's Press Release -

Diabetes

DIABETES CIES SEARCH ENGINE [SELECTED WEBSITES]

Blog Archive

Thursday, September 27, 2007

Innocoll , phase 2 clinical trials for the treatment and prevention of infected diabetic foot ulcers

Link

Keywords

My Blog List

Index